Authors must to disclose all relationships/activities/interests that are related to the content of the submitted manuscript. "Related" means any relation with for-profit or not-for-profit third parties whose interests may be affected by the content of the manuscript. If an author in doubt about whether to list a relationship/activity/interest, it is preferable that (s)he does so.
Interests within the last 36 month of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 36-month time frame must be disclosed if they could reasonably be perceived as influencing the submitted work.
Interests that should be considered and disclosed but are not limited to the following:
Funding: Every submitted article must state each source of financial support for the particular research it describes: research grants or contracts from any entity and/or research support (including salaries, equipment, supplies, provision of study materials, reimbursement for attending symposia, medical writing, article processing charges, etc.) by organizations that may gain or lose financially through publication of this manuscript.
Employment: Recent (while engaged in the research project), present or anticipated employment by any organization that may gain or lose financially through publication of this manuscript.
Financial interests: Stocks or shares in companies that may gain or lose financially through publication of the manuscript; consulting fees or other forms of remuneration from organizations that may gain or lose financially; patents or patent applications whose value may be affected by publication of the manuscript.
Any involvement by pharmaceutical or medical device company employees or medical writers supported by a pharmaceutical or medical device company in the writing of an article must be clearly defined and disclosed in the Interests Disclosure section of the manuscript.
Non-financial interests: Authors are requested to disclose interests that go beyond financial interests that could impart bias on the work submitted for publication such as professional interests, personal relationships or personal beliefs.
When authors have nothing to declare the appropriate statement are required as well.
It is important to note that this policy and the disclosure statements will not be regarded as creating a presumption of impropriety in the existence of financial interests or other relationships of a commercial nature.
Failure to disclose relevant information at the submission stage may result in termination of the review process or reversal of acceptance decisions. If the paper is already published, the Journal reserves the right to post a note on the IBB’s website notifying readers that the authors of the paper violated the IBB disclosure policy.